share_log

Vera Therapeutics——计划在今年晚些时候公布2B期起源试验的96周长期结果

Vera Therapeutics — Plans to release 96-week long-term results from the Phase 2B origin trial later this year

Zhitong Finance ·  May 28 20:08
Vera Therapeutics — Plans to release 96-week long-term results from the Phase 2B origin trial later this year

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment